Market Overview:
The global gamma-aminobutyric acid (GABA) receptor market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of psychiatric disorders, Alzheimer's disease, and chronic obstructive pulmonary disease (COPD). Additionally, the growing awareness about the benefits of gamma-aminobutyric acid (GABA) receptors for treating various medical conditions is also contributing to the growth of this market. The global GABA receptor market is segmented on the basis of type into GABAA and GABAB receptors. The GABAA receptor segment is expected to account for a larger share than GABAB receptors in terms of revenue in 2018. This can be attributed to its higher usage in therapies for attention deficit hyperactivity disorder (ADHD), psychiatric disorders, Alzheimer's disease, chronic obstructive pulmonary disease (COPD), memory impairment, and other applications. On the basis of application, the global GABA receptor market is segmented into ADHD, psychiatric disorders such as depression and anxiety disorder,, Alzheimer's disease,, COPD,, memory impairment,,and other applications such as pain management,. The ADHD segment accounted for a larger share than any other application segments in 2017 and this trend is projected continue duringthe forecast period owingtoits high prevalence rate worldwide .
 Receptor Industry Outlook.svg)
Product Definition:
A gamma-aminobutyric acid (GABA) receptor is a type of receptor located in the brain that binds GABA, a neurotransmitter. The activation of GABA receptors by GABA mediates inhibitory synaptic transmission, which results in reduced neuronal excitability.
GABAA:
GABA is an inhibitory neurotransmitter that binds to the GABAA (?-aminobutyric acid type A) receptor. GABAergic synapse in the brain controls transmission of signals from one neuron to another. The binding of ?-aminobutyric acid (GABA) at its receptor results in inhibition of neuronal activity and promotes calming effect.
The global GABAergic synapse in the brain controls transmission of signals from one neuron to another.
GABAB:
GABA is the major inhibitory neurotransmitter in the mammalian brain. GABAB receptors are seven-transmembrane domain GABAA receptor subfamily. They are responsible for the inhibition of neuronal activity and play an important role in various physiological processes such as learning, memory, sleep regulation and pain sensation. The primary function of a GABAergic neuron is to provide inhibition across the neural synapse; however, some neurons also have excitatory functions (e.g.
Application Insights:
The other application segment includes anxiety disorders, epilepsy, gastrointestinal disorders, and others. The use of gamma-aminobutyric acid (GABA) as a therapeutic agent for the treatment of anxiety is well known in the art. However, owing to lack of interest by pharmaceutical companies for developing drugs specifically targeted towards this application segment, this market has been dominated by non- GABAergic drugs which have limited efficacy in treating anxiety disorders.
The attention deficit hyperactivity disorder (ADHD) segment is expected to grow at a significant rate over the forecast period due to increasing awareness about diagnosis and treatment options among parents worldwide. According to WHO & IASBDA estimates published in 2016 in conjunction with data from 2014 regarding prevalence and incidence rates respectively; approximately 6% children globally are diagnosed with ADHD while around 3% are receiving medication for ADHD each year worldwide making it one of the most common pediatric diseases along with depression etcetera.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about mental health, availability of improved medication, and supportive government initiatives. For instance, as per a survey conducted by Columbia University Mailman School of Public Health in 2016, approximately 19% of adults in U.S were suffering from anxiety disorders and/or panic disorder in any given month.
Growth Factors:
- Increasing demand for GABA receptor agonists for the treatment of various neurological and psychiatric disorders
- Growing research and development activities for the discovery of new GABA receptor agonists
- Rising number of clinical trials evaluating the potential therapeutic benefits of GABA receptor agonists
- increasing geriatric population susceptible to neurological and psychiatric disorders
- growing awareness about the therapeutic benefits of GABA receptor agonists
Scope Of The Report
Report Attributes
Report Details
Report Title
Gamma-Aminobutyric Acid (GABA) Receptor Market Research Report
By Type
GABAA, GABAB
By Application
Attention Deficit Hyperactivity Disorder, Psychiatric Disorders, Alzheimer's Disease, Chronic Obstructive Pulmonary Disease, Memory Impairment, Other
By Companies
AgeneBio, F. Hoffmann-La Roche, Les Laboratoires Servier, Nutra Green Biotechnology, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Gamma-Aminobutyric Acid (GABA) Receptor Market Report Segments:
The global Gamma-Aminobutyric Acid (GABA) Receptor market is segmented on the basis of:
Types
GABAA, GABAB
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Attention Deficit Hyperactivity Disorder, Psychiatric Disorders, Alzheimer's Disease, Chronic Obstructive Pulmonary Disease, Memory Impairment, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AgeneBio
- F. Hoffmann-La Roche
- Les Laboratoires Servier
- Nutra Green Biotechnology
- ...
 Receptor Market Overview.svg)
Highlights of The Gamma-Aminobutyric Acid (GABA) Receptor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- GABAA
- GABAB
- By Application:
- Attention Deficit Hyperactivity Disorder
- Psychiatric Disorders
- Alzheimer's Disease
- Chronic Obstructive Pulmonary Disease
- Memory Impairment
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gamma-Aminobutyric Acid (GABA) Receptor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Receptor Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GABA receptors are proteins that bind GABA, a neurotransmitter. When GABA binds to a receptor, it causes the receptor to activate and send a signal down the neuron. This can reduce anxiety and stress levels in the brain.
Some of the major companies in the gamma-aminobutyric acid (gaba) receptor market are AgeneBio, F. Hoffmann-La Roche, Les Laboratoires Servier, Nutra Green Biotechnology.
The gamma-aminobutyric acid (gaba) receptor market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Gamma-Aminobutyric Acid (GABA) Receptor Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Gamma-Aminobutyric Acid (GABA) Receptor Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Gamma-Aminobutyric Acid (GABA) Receptor Market - Supply Chain
4.5. Global Gamma-Aminobutyric Acid (GABA) Receptor Market Forecast
4.5.1. Gamma-Aminobutyric Acid (GABA) Receptor Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Gamma-Aminobutyric Acid (GABA) Receptor Market Size (000 Units) and Y-o-Y Growth
4.5.3. Gamma-Aminobutyric Acid (GABA) Receptor Market Absolute $ Opportunity
5. Global Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Type
5.3.1. GABAA
5.3.2. GABAB
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Application
6.3.1. Attention Deficit Hyperactivity Disorder
6.3.2. Psychiatric Disorders
6.3.3. Alzheimer's Disease
6.3.4. Chronic Obstructive Pulmonary Disease
6.3.5. Memory Impairment
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Gamma-Aminobutyric Acid (GABA) Receptor Demand Share Forecast, 2019-2029
9. North America Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Application
9.4.1. Attention Deficit Hyperactivity Disorder
9.4.2. Psychiatric Disorders
9.4.3. Alzheimer's Disease
9.4.4. Chronic Obstructive Pulmonary Disease
9.4.5. Memory Impairment
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Type
9.7.1. GABAA
9.7.2. GABAB
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Gamma-Aminobutyric Acid (GABA) Receptor Demand Share Forecast, 2019-2029
10. Latin America Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Application
10.4.1. Attention Deficit Hyperactivity Disorder
10.4.2. Psychiatric Disorders
10.4.3. Alzheimer's Disease
10.4.4. Chronic Obstructive Pulmonary Disease
10.4.5. Memory Impairment
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Type
10.7.1. GABAA
10.7.2. GABAB
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Gamma-Aminobutyric Acid (GABA) Receptor Demand Share Forecast, 2019-2029
11. Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Application
11.4.1. Attention Deficit Hyperactivity Disorder
11.4.2. Psychiatric Disorders
11.4.3. Alzheimer's Disease
11.4.4. Chronic Obstructive Pulmonary Disease
11.4.5. Memory Impairment
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Type
11.7.1. GABAA
11.7.2. GABAB
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Gamma-Aminobutyric Acid (GABA) Receptor Demand Share, 2019-2029
12. Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Application
12.4.1. Attention Deficit Hyperactivity Disorder
12.4.2. Psychiatric Disorders
12.4.3. Alzheimer's Disease
12.4.4. Chronic Obstructive Pulmonary Disease
12.4.5. Memory Impairment
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Type
12.7.1. GABAA
12.7.2. GABAB
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Gamma-Aminobutyric Acid (GABA) Receptor Demand Share, 2019-2029
13. Middle East & Africa Gamma-Aminobutyric Acid (GABA) Receptor Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Application
13.4.1. Attention Deficit Hyperactivity Disorder
13.4.2. Psychiatric Disorders
13.4.3. Alzheimer's Disease
13.4.4. Chronic Obstructive Pulmonary Disease
13.4.5. Memory Impairment
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Volume Forecast by Type
13.7.1. GABAA
13.7.2. GABAB
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Gamma-Aminobutyric Acid (GABA) Receptor Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Gamma-Aminobutyric Acid (GABA) Receptor Market: Market Share Analysis
14.2. Gamma-Aminobutyric Acid (GABA) Receptor Distributors and Customers
14.3. Gamma-Aminobutyric Acid (GABA) Receptor Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AgeneBio
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. F. Hoffmann-La Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Les Laboratoires Servier
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nutra Green Biotechnology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ...
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
